Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis.
E J
EJ
Giltay
D
D
van Schaardenburg
L J
LJ
Gooren
B M
BM
von Blomberg
J C
JC
Fonk
D J
DJ
Touw
B A
BA
Dijkmans
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002478:Cells, Cultured; D003687:Dehydroepiandrosterone / Q000097:blood / Q000627:therapeutic use*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D016131:Lymphocyte Subsets / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects; D017698:Postmenopause; D016896:Treatment Outcome
D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate